Full Name
Li Shu Chuen
(not current staff)
Variants
Shu, C.L.
Li, S.-C.
Li, S.C.
Shu-Chuen, L.
Luo, N.
 
Main Affiliation
 
Faculty
 
Email
phalisc@nus.edu.sg
 
Other emails
 

Publications

Results 1-9 of 9 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
1Mar-2004What Is Next for Pharmacoeconomics and Outcomes Research in Asia?Doherty, J.; Kamae, I.; Lee, K.K.C.; Li, H.; Li, S.-C. ; Liu, G.G.; Tarn, Y.-H.; Yang, B.-M.
2Oct-2004Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4Zhou, S. ; Chan, E. ; Lim, L.Y. ; Boelsterli, U.A.; Li, S.C. ; Wang, J.; Zhang, Q.; Huang, M.; Xu, A.
3Jul-2005Metabolism and transport of oxazaphosphorines and the clinical implicationsZhang, J.; Tian, Q. ; Sui, Y.C. ; Shu, C.L. ; Zhou, S. ; Duan, W.; Zhu, Y.-Z.
42006Is the childhood asthma questionnaire a good measure of health-related quality of life of asthmatic children in Asia? Validation among paediatric patients with asthma in SingaporeChong, L.-Y.; Chay, O.-M.; Shu-Chuen, L. 
5Jun-2004Drug utilization review of risperidone for outpatients in a tertiary referral hospital in SingaporeLuo, N. ; Koh, Y. ; Tan, C.H.; Kua, E.H.; Li, S.C. 
6Jun-2005Do health-related quality-of-life domains and items in knee and hip osteoarthritis vary in importance across social-cultural contexts? A qualitative systematic literature reviewXie Feng ; Li, S.-C. ; Thumboo, J. 
7May-2011Corrigendum to "Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr stage transition times" [Parkinsonism Relat Disord 17 (2011) 194-197]Zhao, Y.J.; Wee, H.L. ; Au, W.L.; Seah, S.H.; Luo, N. ; Li, S.C. ; Tan, L.C.S.
82003An overview of community pharmacist interventions: Assessing cost-effectiveness and patients' willingness to payLi, S.C. 
92005A new algorithm to identify the causality of adverse drug reactionsKoh, Y. ; Shu, C.L.